Adjunctive lacosamide in clinical practice: sodium blockade with a difference?

Abstract

Lacosamide (LCM) was licensed in the United Kingdom in 2008 for the adjunctive treatment of partial-onset seizures. It exerts its effect by enhancing sodium channel slow inactivation. This article reports preliminary outcomes with adjunctive LCM in the everyday clinical setting. To date, 113 patients (57 males, 56 females; aged range=18-74 years, median=39… (More)
DOI: 10.1016/j.yebeh.2011.07.035

Topics

2 Figures and Tables

Cite this paper

@article{Stephen2011AdjunctiveLI, title={Adjunctive lacosamide in clinical practice: sodium blockade with a difference?}, author={Linda J. Stephen and Kevin Kelly and Pamela J Parker and Martin J Brodie}, journal={Epilepsy & behavior : E&B}, year={2011}, volume={22 3}, pages={499-504} }